-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FHFrgtTCbROj6lgpAR5N1+6moZpFs6U+IW+5S/3oTJTUI3a8se4gDgROaSYEyMhH BRpaS2v4Lugugj3h8TW6qQ== 0000077182-99-000004.txt : 19990310 0000077182-99-000004.hdr.sgml : 19990310 ACCESSION NUMBER: 0000077182-99-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19990301 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 19990309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PENNEY J C CO INC CENTRAL INDEX KEY: 0000077182 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DEPARTMENT STORES [5311] IRS NUMBER: 135583779 STATE OF INCORPORATION: DE FISCAL YEAR END: 0126 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-00777 FILM NUMBER: 99560878 BUSINESS ADDRESS: STREET 1: 6501 LEGACY DR CITY: PLANO STATE: TX ZIP: 75024-3698 BUSINESS PHONE: 2144311000 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) - March 1, 1999 J. C. PENNEY COMPANY, INC. (Exact name of registrant as specified in its charter) Delaware 1-777 13-5583779 (State or other jurisdiction (Commission (IRS Employer of incorporation) File No.) Identification No.) 6501 Legacy Drive 75024-3698 Plano, Texas (Address of principal (Zip code) executive offices) Registrant's telephone number, including area code: (972) 431-1000 Item 5. Other Events. ______ ____________ On March 1, 1999, J. C. Penney Company, Inc. (the "Company") completed its acquisition of Genovese Drug Stores, Inc. As noted in the press release announcing the completion of the transaction, which is incorporated by reference herein as Exhibit 20 hereto, each Genovese stockholder will receive 0.6709 of a share of the Company's Common Stock of 50c par value for each share of Genovese common stock held by such stockholder. Item 7. Financial Statements and Exhibits. ______ _________________________________ (c) Exhibits. 20 J. C. Penney Company, Inc. press release dated March 1, 1999. SIGNATURES __________ Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. J. C. PENNEY COMPANY, INC. /s/ C. R. Lotter _________________________ C. R. Lotter Executive Vice President, Secretary and General Counsel Date: March 9, 1999 Exhibit Index Exhibit Number Description ______ ___________ 20 J. C. Penney Company, Inc. Press Release dated March 1, 1999. EX-20 2 NEWS RELEASE - GENOVESE DRUG STORES, INC. ACQ. Exhibit 20 __________ JCPENNEY NEWS RELEASE JCPENNEY COMPLETES ACQUISITION OF GENOVESE DRUG STORES, INC. PLANO, TX, March 1, 1999 - J. C. Penney Company, Inc. (JCP/NYSE) announced at today's Special Meeting of Stockholders of Genovese Drug Stores, Inc., that Genovese's stockholders approved the merger of Genovese with Legacy Acquisition Corp., a wholly owned subsidiary of JCPenney. This approval represents the completion of JCPenney's acquisition of Genovese. As a result of the merger, Genovese stockholders will receive 0.6709 of a share of JCPenney common stock for each share of Genovese common stock held prior to the merger. Contact: Public Relations Investor Relations ________________ __________________ Duncan Muir Wyn Watkins Eli Akresh 972-431-1329 (972) 431-1972 (972) 431-2207 Public Relations J. C. Penney Company, Inc., 6501 Legacy Drive, Plano, Texas 75024 -----END PRIVACY-ENHANCED MESSAGE-----